Filing Details
- Accession Number:
- 0001192482-11-000120
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-10 17:33:56
- Reporting Period:
- 2011-05-06
- Filing Date:
- 2011-05-10
- Accepted Time:
- 2011-05-10 16:33:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1301081 | Pharmasset Inc | VRUS | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1397331 | Iii F Robert Williamson | 303A College Road East Princeton NJ 08540 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.001 Par Value Per Share | Acquisiton | 2011-05-06 | 20,000 | $3.00 | 34,666 | No | 4 | M | Direct | |
Common Stock, $.001 Par Value Per Share | Disposition | 2011-05-06 | 31,666 | $104.36 | 3,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2011-05-06 | 20,000 | $0.00 | 20,000 | $3.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2014-08-10 | No | 4 | M | Direct |
Footnotes
- Represents the weighted average sales price for all shares for price increments ranging from $104 to $105.25.
- The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- These options were granted on August 10, 2004. 25% were vested upon the grant, 25% became vested on the one-year anniversary of the grant and 6.25% became vested quarterly thereafter.